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Most tests of association between DNA sequence variation and quantitative phenotypes in samples of randomly
chosen individuals rely on specification of genotypic strata followed by comparison of phenotypes across these strata. This
strategy often succeeds when phenotypic differences are caused by one or two single nucleotide polymorphisms (SNPs)
among the surveyed markers. However, when multiple-SNP haplotypes account for observed phenotypic variation,
identification of the best partitioning requires examination of an inordinate number of SNP combinations. An alternative
approach is to rank individuals by their phenotypic measures and ask whether attributes of the genotypic variation
show a non-random distribution along this phenotypic ranking. One simple version of this strategy selects the top and
bottom tails of the distribution, and then tests whether genotypes from these two samples are drawn from a single
population. This framework does not require the recovery of phased haplotypes and allows contrasts between large
numbers of sites at once. We use a method based on this approach to identify associations between plasma triglyceride
level, a risk factor for cardiovascular disease, and multi-site genotypes located in the APOA1/C3/A4/A5 cluster of
apolipoprotein genes in unrelated individuals (1,071 African-American females, 780 African-American males, 1,036
European-American females, and 930 European-American males) sampled from four US cities as part of the Coronary
Artery Risk Development in Young Adults (CARDIA) study. Method performance is investigated using simulations
that model genealogical variation and different genetic architectures. Results indicate that this multi-site test can identify
genotype-phenotype associations with reasonable power, including those generated by some simple epistatic models.
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INTRODUCTION
A complete understanding of genetic variation
underlying risk of disease requires identification of
the functional DNA polymorphisms. With increas-
ing availability of molecular markers, genomic
scanning for association between phenotypic
variation and randomly chosen polymorphisms,
conducted with or without pedigree informa-
tion, provides promise as a method for identi-
fying disease susceptibility genes. When clear
candidate genes exist, surveys of densely spaced
polymorphisms within these genes in large sam-
ples of individuals can also provide crucial insights
into variation at the gene level and its statistical
association with variation in disease risk.
A common approach to candidate gene analysis
involves the collection of phenotypic measure-
r 2006 Wiley-Liss, Inc.
ments and genotypes for a sample of unrelated
individuals and comparison of phenotypes among
classes defined by single nucleotide polymorph-
ism (SNP) genotypes using analysis of variance or
related methods. This ‘‘genotype-first’’ paradigm
is powerful if the SNPs that contribute to risk
are in the marker set, or if they are in linkage
disequilibrium with the unobserved causal SNPs.
Nevertheless, two arguments suggest that alter-
native approaches may be worthwhile in cases
involving quantitative traits. First, much of the
power for detecting associations between poly-
morphism in candidate genes and complex trait
variation derives from individuals with extreme
phenotypes [Schork et al., 2000]. This idea has
been used to identify maximally informative
markers in experimental crosses designed to
map quantitative traits [‘‘bulked segregant analy-
sis’’; Michelmore et al., 1991].
A second reason for considering alternatives
to the ‘‘genotype-first’’ framework for candidate
gene studies is the inherent complexity that arises
when multiple polymorphic sites are analyzed
simultaneously. The rapid increase in the number
of multi-site genotypes that accompanies the
addition of SNPs shrinks the sample size for
each genotypic class, challenging the accurate
estimation of phenotypic means and variances
associated with specific genotypic classes and
reducing power. Additionally, the genotype-first
approach will often fail in cases where combina-
tions of SNPs that exert no individual marginal
effects explain the observed phenotypic variation.
Tests of association that benefit from the inclusion
of more neighboring SNPs are desirable. Methods
that evaluate the relationship between phenotype
and genotype for a large number of site combina-
tions have been developed and applied with
some success [Nelson et al., 2001; Culverhouse
et al., 2004; Jannot et al., 2003], but extension of
these approaches to many sites is challenging.
Another strategy assesses the correlation of
phenotypes and haplotypes in a cladistic context
[Templeton et al., 1987; Seltman et al., 2003],
but these procedures currently require knowledge
of haplotype phase and resolution of the geneal-
ogy, and propagation of the uncertainty asso-
ciated with these inferences can be prohibitively
cumbersome.
These considerations motivate an approach to
association testing that uses the phenotypic
distribution to define classes of genotypes for
comparison. Associations between genotype and
phenotype can be identified as genotypic differ-
entiation between groups of individuals drawn
from opposite ends of the phenotypic spectrum.
For example, Cohen et al. [2004] discovered that
groups of individuals with high vs. low levels of
high-density lipoprotein cholesterol differ in the
frequencies of non-synonymous SNPs found in
candidate genes. The power of this ‘‘phenotype-
first’’ method has been investigated considering
one site at a time [Schork et al., 2000; Tenesa et al.,
2003], and the rationale has been discussed in the
context of selective genotyping and DNA pooling
[Darvasi and Soller, 1992; Sham et al., 2002;
Carlson et al., 2004]. Here, we extend this frame-
work to compare phenotypically extreme groups
at many sites simultaneously, an important
advantage when multiple sites determine the
functional haplotype.
Analysis of cardiovascular disease seems parti-
cularly amenable to a candidate gene approach.
Loss-of-function mutations in several candidate
genes co-segregate with familial disorders, and a
connection between quantitative variation in risk
factors and candidate gene polymorphism has
been established. Elevated triglyceride (TG) level
is one such risk factor [Austin et al., 1998] that
has received considerable attention. Substantial
genetic variation for TG level has been detected
[Hunt et al., 1989; Brenn, 1994], with biochemical
and association studies providing clear candidate
genes for this variation.
Genes encoding the apolipoproteins, lipid-bind-
ing proteins involved in the transport of lipids
in the plasma, are particularly suitable targets for
candidate gene surveys of TG-related traits. One
48 kb region of chromosome 11q23–q24 contains
four apolipoprotein genes, APOA1, APOC3,
APOA4, and APOA5 [Karathanasis, 1985; Pennac-
chio et al., 2001]. Several population-based asso-
ciations between TG level and polymorphisms
located in the APOA1/C3/A4/A5 cluster have been
reported [Groenendijk et al., 2001; Pennacchio
et al., 2002; Talmud et al., 2002; Austin et al., 2004;
Evans et al., 2003; Kao et al., 2003; Lai et al., 2003;
Eichenbaum-Voline et al., 2004; Klos et al., 2005].
Here, we compare variation in SNPs densely
spaced across the APOA1/C3/A4/A5 region
between subgroups of healthy, young individuals
with extreme differences in TG level. We identify
genotype-phenotype associations in the form of
multi-site genotypic differentiation between
groups of individuals sampled from the tails of
the phenotypic distribution. Performance of this
multi-site method is evaluated using computer
simulations.
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METHODS
DATA COLLECTION
The complete dataset from which subsets of
phenotypes and genotypes were drawn for analysis
was collected from individuals surveyed at four
field centers (Birmingham, AL; Chicago, IL; Min-
neapolis, MN; and Oakland, CA) as part of the
longitudinal Coronary Artery Risk Development in
Young Adults (CARDIA) study [Friedman et al.,
1988; Liu et al., 1989]. In the CARDIA study,
subjects were unrelated African-American females
(n 5 1071), African-American males (n 5 780), Eur-
opean-American females (n 5 1036), and European-
American males (n 5 930), ranging in age from 18
to 30 years. Individuals were selected without
reference to health. Venous blood was drawn after
a 12-h fast and plasma TG levels were determined
using standard enzymatic methods [Warnick, 1986].
The candidate gene region, the APOA1/C3/A4/A5
gene cluster, is located on chromosome 11q23–q24
and is approximately 48 kb in size. A resequencing
study of this cluster surveyed 17.7 kb, including the
intergenic region between APOA1 and APOC3, the
exons, intervening introns, and approximately
1000 bp upstream of the APOA1, APOC3, APOA4,
and APOA5 genes in 24 unrelated individuals from
each of three populations: African-Americans from
Jackson, MS; Europeans from North Karelia, Fin-
land; and European-Americans from Rochester,
MN [Fullerton et al., 2004]. Average levels of
linkage disequilibrium between all pairs of poly-
morphic sites from across the region (measured by
R2) ranged between 0.087 and 0.122 [depending on
the population sampled; Fullerton et al., 2004],
suggesting that the simultaneous use of multiple
sites in association testing may be worthwhile. The
present study focused on genotypes for 80 SNPs
(Fig. 1) discovered in this survey. Each SNP was
genotyped in the 3,817 individuals (described
above) by PCR amplification of genomic DNA, a
short extension reaction across the polymorphic
site, and detection of allele-specific mass differ-
ences of the extension product by mass spectro-
metry. Allele detection and genotype calling
was performed using a MassARRAY System
from Sequenoms (San Diego, CA). Blind dupli-
cates were included for assessing the quality of the
SNP genotyping.
STATISTICAL ANALYSIS
To reduce skewness and account for important
covariates, plasma TG values were adjusted prior
to analysis by logarithmic transformation, fitting
an ethnic/gender/field center specific linear
regression model containing age, age2, age3 and
BMI, and adding the residuals to the ethnic/
gender-specific grand mean. Because the sexes
differ in cardiovascular disease risk [Barrett-
Connor, 1997], males and females were analyzed
separately. African-Americans and European-
Americans were also treated separately due to
variation in allele frequencies and linkage dis-
equilibrium in the surveyed SNPs [Fullerton et al.,
2004] and the expectation of differentiation at
other, unlinked regions that may interact with
polymorphisms in the APOA1/C3/A4/A5 cluster.
Individuals with extreme phenotypes were
selected from the tails of the TG distributions of
each population-sex group in the CARDIA study
separately. We conducted three sets of analyses,
sampling from the upper and lower 5%, 10%,
and 15% of the distributions. These quantiles were
chosen to balance the increase in power derived
from contrasting more extreme phenotypes
with the eventual decrease in power caused
by reducing sample size [Schork et al., 2000;
Tenesa et al., 2003]. The genotypic state of each
SNP in each selected individual was recoded
by comparison to sequence from one common
chimpanzee into three categories (both alleles
identical to chimpanzee, both alleles different
from chimpanzee, or one allele different from
chimpanzee (heterozygote); Fullerton et al.,
2004). The unphased multi-site genotype of each
individual was represented by a string of these
recoded genotypes.
We modified the SNN statistic and program
[Hudson, 2000; http://home.uchicago.edu/
rhudson1/source/permtest.html], which was
devised to detect multi-site haplotypic differentia-
tion among populations, to compare collections of
unphased genotypes sampled from the upper and
lower tails of the phenotypic distribution. Follow-
ing Hudson [2000], we compared individual i to
each other individual. In our comparison between
diploid genotypes, alternative homozygotes were
assigned a value of 1, heterozygote-homozygote
contrasts were assigned a value of 0.5, and
identical genotypes (homozygote-homozygote
and heterozygote-heterozygote) were assigned a
value of 0, at each site. These distances were
summed across sites. The number of individuals
that showed the smallest number of differences
with i was determined. Then, the fraction of these
‘‘nearest-neighbor’’ individuals that were found
in the same phenotypic group as i (Xi) was
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SNN measures the tendency of individuals with
similar sequences to be found in the same group.
When phenotypic variation is associated with
multi-site genotypes, we expect individuals with
the same phenotype to exhibit more similar
genotypes. Statistical significance was assessed
by permutating sequences between phenotypic
groups 10,000 times. This approach uses sequence
similarity without requiring the reconstruction
of genealogies or phase information, and allows
Fig. 1. Locations of 80 SNPs from the APOA1/C3/A4/A5 gene cluster used in this study. Exon structure, direction of transcription,
and regulatory regions are also shown.
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the incorporation of large numbers of poly-
morphic sites.
We applied the multi-site test to several combi-
nations of SNPs from the APOA1/C3/A4/A5
region. First, we asked whether individuals with
high vs. low TG levels differed in genotypes
comprised of surveyed SNPs from across the gene
cluster. This was a single global test of association
between variation in the APOA1/C3/A4/A5 candi-
date region and TG level. Next we looked for
genotypic differentiation between the phenotypic
tails by grouping SNPs from the same gene
(one test each for APOA1, APOC3, APOA4, and
APOA5). This set of contrasts was motivated
by the notion that functional polymorphisms
within genes may interact. Finally, because non-
synonymous variation is likely to affect protein
function, we also evaluated evidence for differ-
entiation between genotypes formed by combin-
ing amino acid variants from across the entire
region. Due to the relatively small number of tests,
we did not adjust statistical significance criteria
for the performance of multiple tests.
Statistical power was evaluated by computer
simulation. To mimic variation in an individual
gene from the APOA1/C3/A4/A5 region, 20-site
genotypes sampled from 4 kb of sequence were
simulated for 1,000 diploid individuals and
phenotypes were generated under three genetic
models (Appendix). All simulations compared
collections of genotypes from the upper and lower
10% (100 individuals from each tail) of the
phenotypic distribution. Power was estimated as
the fraction of 1,000 simulation replicates that
yielded Po0.05. The false-positive rate (also using
a significance criterion of Po0.05), estimated by
simulating population histories with all sites
exhibiting no phenotypic effect, was 0.053.
RESULTS
MULTI-SITE ASSOCIATION TESTING ACROSS
THE APOA1/C3/A4/A5 REGION
Populations sampled from opposite ends of the
TG distribution harbored different collections of
multi-site genotypes in several contrasts (Table I).
TABLE I. Results of tests comparing multi-site genotypes from the APOA1/C3/A4/A5 gene cluster between the tails of
the TG distribution
5% Tailsa 10% Tails 15% Tails
Subset Stratumb Sitesc SNN P Sites SNN P Sites SNN P
All sites EM 64 0.5358 0.2252 65 0.5697d 0.0294 65 0.5193 0.2428
All sites EF 60 0.5159 0.3407 61 0.5089 0.3752 67 0.5139 0.2933
All sites AM 69 0.4892 0.5195 74 0.5567 0.0886 77 0.4737 0.7488
All sites AF 75 0.5204 0.2750 76 0.4864 0.6354 76 0.4983 0.5031
APOA1 EM 17 0.5582 0.0186 18 0.5695 0.0003 18 0.5249 0.0320
APOA1 EF 16 0.4739 0.7402 16 0.4748 0.8816 17 0.4946 0.5966
APOA1 AM 18 0.4731 0.6997 19 0.4911 0.5739 19 0.4682 0.9483
APOA1 AF 18 0.4950 0.4835 18 0.5138 0.1873 18 0.5084 0.2241
APOC3 EM 18 0.5577 0.0627 18 0.5679 0.0033 18 0.5089 0.2499
APOC3 EF 16 0.5134 0.3223 16 0.5182 0.1991 19 0.5058 0.3255
APOC3 AM 24 0.4696 0.6695 25 0.5444 0.0962 25 0.4926 0.5681
APOC3 AF 25 0.5486 0.1262 25 0.4851 0.6591 25 0.4843 0.7338
APOA4 EM 14 0.5239 0.2089 14 0.5426 0.0231 14 0.5304 0.0286
APOA4 EF 14 0.5065 0.3375 15 0.5165 0.1374 16 0.5155 0.1150
APOA4 AM 12 0.4522 0.8496 15 0.5319 0.0744 17 0.5382 0.0145
APOA4 AF 15 0.5061 0.3221 15 0.5112 0.1681 15 0.5172 0.0361
APOA5 EM 15 0.5483 0.0476 15 0.5773 0.0001 15 0.5526 0.0003
APOA5 EF 14 0.5163 0.2261 14 0.5250 0.0406 15 0.5278 0.0054
APOA5 AM 15 0.4911 0.5121 15 0.4957 0.5135 16 0.4989 0.4621
APOA5 AF 15 0.4992 0.4680 15 0.4745 0.8118 15 0.4922 0.6335
Non-synonymous EM 7 0.5107 0.2484 7 0.5527 0.0013 7 0.5202 0.0221
Non-synonymous EF 7 0.5287 0.0444 7 0.5124 0.0916 7 0.5105 0.0701
Non-synonymous AM 5 0.4868 0.5652 5 0.5073 0.2042 5 0.5076 0.1298
Non-synonymous AF 7 0.5149 0.1461 7 0.5147 0.0382 7 0.5044 0.1548
aPercentage of individuals drawn from the upper and lower tails of the TG distribution.
bEM 5 European-American males; EF 5 European-American females; AM 5 African-American males; AF 5 African-American females.
cNumber of variable sites in the combined sample from the tails of the TG distribution.
dValues in bold were statistically significant at the Po0.05 level, without correcting for the performance of multiple tests.
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European-American males showed the strongest
evidence of association, with genotypic differen-
tiation between the phenotypic tails observed in
separate tests of each gene. Association tests at
APOA1 and APOA5 showed statistical signifi-
cance (Po0.05) across all thresholds (5%, 10%,
or 15%) used to define the phenotypic extremes.
Seven-site genotypes composed of all surveyed
non-synonymous variants from across the gene
cluster (five sites in APOA4 and two sites in
APOA5) also yielded evidence of association.
Comparison of individuals from the upper and
lower 10% of the TG distribution combining sites
from across the APOA1/C3/A4/A5 region again
identified genotypic differentiation, although this
result was not replicated at other thresholds.
Although population-sex groups other than
European-American males generally showed
weaker evidence for genotypic differentiation
between the tails of the TG distribution, some
associations emerged. European-American females
showed evidence of association in two sets of
tests: those involving multi-site genotypes from
APOA5 and those involving seven-site non-
synonymous genotypes. APOA4 genotypes were
associated with TG levels in both African-
American males and African-American females
(when comparing the upper and lower 15% of
the distribution). Interestingly, African-American
females also showed signs of significant genotypic
differentiation between the phenotypic tails at
non-synonymous sites (using a threshold of 10%),
even though none of these sites appeared to be
related to the phenotype in single-site tests (data not
shown). Some of the surveyed non-synonymous
sites have been previously connected with TG level,
including the S19W variant in APOA5 (site 29009),
which appears to affect TG in both healthy
and hypertriglyceridemic individuals [reviewed in
Shoulders et al., 2004; Klos et al., 2005].
POWER
Figure 2 illustrates the effects of heritability,
mode of SNP action, and recombination rate on
power for the multi-site test. Considering that
only one-fifth (upper 10%1lower 10%) of the total
number of individuals was used, the multi-site
method retained good power to detect associa-
tions under the conditions we investigated. Across
recombination rates, power was at least 80%
for the additive and epistatic cases in which
associations explained 5% or more of the pheno-
typic variance.
Power was affected by the mode of action of the
causal site(s). Across the spectrum of heritabilities,
the method showed greater power to detect
associations caused by additive SNPs than those
caused by recessive action (Fig. 2a and b). When
genetic variance was generated purely by an
interaction between two sites (additive by addi-
tive epistasis), the power was similar to that
observed for additive models (Fig. 2c). This
result was probably caused by the deviation of
allele frequencies from 0.5, which can change the
additive and dominance variance components
[Falconer and Mackay, 1996], thereby creating
marginal population associations even when
phenotypic differences are caused by epistasis.
Power was also higher for the epistatic model than
for two-site additive models (data not shown).
We simulated recombination fractions appro-
priate for a 4 kb region, assuming an effective
population size of 10,000. Power decreased with
increasing recombination rate, although not dra-
matically. Comparing the largest (4Nr 5 4.8, cor-
responding to 3 cM/Mb) and smallest (4Nr 5 0)
rates simulated, the average reduction in power
across genetic architectures was 5%.
DISCUSSION
THE ROLE OF APOA1/C3/A4/A5 GENOTYPES
IN TG LEVELS
We uncovered evidence of multi-site genotypic
differentiation between individuals with different
TG levels, from across the APOA1/C3/A4/A5
cluster. Genotypes constructed from sites grouped
by (i) gene cluster membership, (ii) location in
individual genes, and (iii) non-synonymous nat-
ure each displayed heterogeneity among pheno-
typically defined populations. Although combi-
nations of sites for testing were chosen based on
biological (and not statistical) criteria, the identi-
fication of the multi-site associations between
genotype and phenotype we report here would
be difficult to accomplish using genotype-first
methods. In this context, a genotype-first associa-
tion test would require estimation of phenotypic
means and variances for each observed haplotype
(genotype) formed by combining polymorphism
at large numbers of sites. Our approach suggests
that polymorphisms in the APOA1/C3/A4/A5 gene
cluster affect TG levels and that this relationship
is visible in multi-site, unphased genotypes.
Our analyses revealed stronger evidence for
associations between TG level and genotypes in
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the APOA1/C3/A4/A5 gene cluster among Eur-
opean-American males than in other population-
sex strata. This discrepancy has several potential
causes. First, levels of linkage disequilibrium
might be higher in European-American males,
providing increased power for detecting associa-
Fig. 2. Power of multi-site approach to detect associations. Genotypes were simulated at 20 sites for 1,000 diploid individuals, and 100
individuals were drawn from each phenotypic tail for comparison. Power is the fraction of 1,000 simulations with Po0.05. (A) One-site
additive model. (B) One-site fully recessive model. (C) Two-site (additive by additive) epistatic model. 4Nr is the per-locus population
recombination rate.
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tions. For example, populations with predomi-
nantly European ancestry tend to show higher
linkage disequilibrium at loci sampled from
throughout the genome than do populations
derived from Africa [Tishkoff et al., 2000; Reich
et al., 2001], an observation that is likely due to the
reduced effective population size of European
populations. However, the relative paucity of
genotype-phenotype associations seen in Eur-
opean-American females in our study argues
against the idea that differences in linkage
disequilibrium completely explain the results.
Second, the relationship between TG level and
genotype may differ between European-American
males and the other strata.
A third possibility is a combination of increased
linkage disequilibrium in European-Americans
and a different genetic basis for variation in TG
levels among males and females. Biological
differences among the sexes in the development
of cardiovascular disease, and related risk factors,
have been identified [Barrett-Connor, 1997].
Studies of the association between plasma TG
levels and variation in genes from the APOA1/C3/
A4/A5 cluster suggest effects of sex in some cases
[Lai et al., 2003], but not in others [Pennacchio
et al., 2002]. Differences in subject age between
studies (our data come from healthy, 18–30-year-
olds, while other studies focus on middle-aged,
diseased individuals) complicate comparisons
between results, however.
ASSOCIATION TESTING BY MULTI-SITE
COMPARISON OF PHENOTYPICALLY
DEFINED STRATA
Investigators have previously used genotypic
comparisons among individuals with extreme
phenotypes in linkage mapping [Michelmore
et al., 1991; Darvasi and Soller, 1992; Risch and
Zhang, 1995], the transmission disequilibrium test
[Deng and Li, 2002], and association testing
among unrelated individuals [Schork et al., 2000;
Tenesa et al., 2003; Cohen et al., 2004]. We have
extended this approach to measure multi-site
genotypic differentiation between the tails of the
phenotypic distribution.
Several caveats accompany our method. First,
the best criteria for delimiting the sections of the
phenotypic distribution for comparison are un-
clear. We reported results using three tail sizes:
5%, 10%, and 15%. While some associations
between TG level and multi-site genotypes were
observed across thresholds (in European-Amer-
ican males), other associations were only discov-
ered using particular criteria. The optimal tail size
must balance the benefits of comparing indivi-
duals with increasingly divergent phenotypes
with the accompanying reduction in sample size.
One study of association testing in the context
of DNA pooling estimated that for individual sites
harboring common alleles with additive effects,
sampling 27% from each tail of the phenotypic
distribution represents the optimal design [Jawaid
et al., 2002], while other authors suggested 5%
[Tenesa et al., 2003]; similar calculations have not
been reported for multi-site tests. Whether the
method may benefit from unequal sampling from
the tails of the distribution under certain genetic
architectures [Jawaid et al., 2002] also remains
to be investigated.
Our simulations focused on relatively simple
genetic architectures, with genetic variation attrib-
uted to one or two SNPs. Although such a
scenario is reasonable for candidate genes under-
lying variation in complex traits, evaluation of test
performance under models with more than two
causal sites would provide a more biologically
sound assessment. The possible increase in effi-
ciency derived from focusing on the tails of the
phenotypic distribution is also partly obviated by
the restriction to considering one phenotypic
dimension at a time. Furthermore, as is the case
for several other available methods, false positives
could arise with our approach if the sample is
comprised of multiple populations showing both
phenotypic and genotypic differences.
Our multi-site method features several impor-
tant advantages over more traditional approaches
to association testing. First, the method directly
and simultaneously uses information from many
polymorphic sites in a candidate region. This
feature facilitates the identification of associations
generated by epistasis and reduces the number
of tests required to find associations. Second, our
test uses unphased genotypes, obviating the need
for haplotype reconstruction. Although knowl-
edge of haplotype configurations may aid
attempts to correlate genotype with pheno-
type [Clark, 2004], statistical inference of phase
introduces uncertainty that complicates subse-
quent association testing and reduces power
[Morris et al., 2004; Schaid, 2004]. Third, the
delineation of groups for comparison based on
the phenotype avoids reductions in power that
accompany genotype-first approaches. Finally,
the tail-based method requires genotypes from
fewer individuals, raising the possibility of
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selectively genotyping individuals based on their
phenotypic values.
Several extensions to the multi-site contrast
between phenotypic categories can be imagined.
For example, samples formed by combining
individuals with extreme phenotypes may exhibit
deeper genealogical splits and therefore harbor
more intermediate-frequency variants than sam-
ples drawn randomly with respect to phenotype.
Furthermore, the phenotype-first approach is not
limited in application to the tails of the phenotypic
distribution. Comparing patterns of multi-site
genotypic variation across multiple segments of
the phenotypic distribution may yield additional
insights, particularly when sites have small
phenotypic effects (so that alternative geno-
types may not be clearly concentrated in the tails)
or interactions between sites are important
(since genetic background may differ across the
phenotypic distribution). Because the identifica-
tion of associations in this context is equivalent to
detecting population differentiation, any ap-
proach that contrasts patterns of variation be-
tween populations based on multiple sites could
be used. Strategies that explicitly accommodate
variation in the underlying genealogy [Zöllner
and Pritchard, 2004] seem especially promising.
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OF THE MULTI-SITE TEST
The coalescent provides a useful tool for
investigating the performance of tests that depend
on genealogical history [Hudson, 1990], including
methods designed to associate genotype with
phenotype [Long and Langley, 1999; Zondervan
and Cardon, 2004]. Coalescent simulations gen-
erate samples of genotypes by (i) creating random
genealogies and (ii) adding mutations to these
genealogies. To mimic variation in an individual
gene from the APOA1/C3/A4/A5 region, 20-site
haplotypes sampled from 4 kb of sequence were
simulated, with recombination (see below), for
2,000 chromosomes (1,000 diploid individuals),
using the MS program [Hudson, 2002]. Simula-
tions assumed that all variation was neutral and
derived from a population at demographic equili-
brium. Haplotypes were randomly paired to form
genotypes. One or two SNPs (the first in the
sequence, or the first and the last, respectively)
were used to determine the genotypic effect
influencing the phenotype. Only simulation repli-
cates yielding allele frequencies of at least 0.1 at
these quantitative trait nucleotides (QTN) were
retained. Genetic effects (gj) were generated for
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each individual from these QTN according to the
model [Gavrilets and de Jong, 1993].
gj ¼ a im þ ip
 




where im and ip are the two alleles (each with state 0
or 1) that individual j carries at the QTN, a
represents an additive effect, d denotes a dom-
inance effect, and e is an epistatic effect (the
epistatic case modeled here was additive by
additive epistasis). The genetic variance in the
population (vg) was measured as the variance of g.
For each individual, a random environmental






and f is the desired fraction of phenotypic
variation that is genetic [the broad-sense herit-
ability; Falconer and Mackay, 1996].
Individuals were then selected from the upper
and lower 10% of the phenotypic distribution
(100 individuals from each tail) and their
genotypes were compared using the multi-site
test. We evaluated power under varying levels
of recombination (the population recombina-
tion rate, 4Nr 5 0, 1.6, 3.2, and 4.8, where
N is the effective population size and r is the
per-locus recombination rate). These values
were chosen to sample a reasonable range of
recombination rates for the APOA1/C3/A4/A5
region [0, 1, 2, and 3 cM/Mb; Kong et al.,
2002], assuming an effective population size
of 10,000. For each recombination rate, we
investigated 10 broad-sense heritabilities (ranging
from 1% to 10% of the phenotypic variance
explained) and three modes of action (one-site
additive, one-site fully recessive, and two-site
epistatic).
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